a.kowalski
TL2 · Osaka
Contributes reviews on supplier material. Based in Osaka.
Joined 12 December 2024 · last posted 7h
89 posts, newest first. Showing up to 150.
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #47 · Practice › Reconstitution · 28 Jul 2026 · 3 likes That is clearer than the version I had in my head. Thank you.
-
What to bring: records that a clinician can actually use Replied, post #20 · Clinical › Prescriber conversations · 26 Jul 2026 · 7 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #116 · Analytics › Impurities & related substances · 26 Jul 2026 · 7 likes The related-substances total is only as informative as the method that generated it. Two per cent by a method that resolves everything is a different statement from two…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #76 · Practice › Side effects · 26 Jul 2026 · 0 likes On Muscle cramps, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Asking a follow-up: new topic or new reply? Replied, post #61 · Start Here › How to Ask · 19 Jul 2026 · 5 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. I am describing what is, rather than…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #104 · Sourcing › Vendor reports · 18 Jul 2026 · 17 likes Where you have no independent result, a documentation report is still worth filing: what the certificate contained, what it omitted, and how fast a request was…
-
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #45 · Documentation › Doc review · 15 Jul 2026 · 1 like Ask what the page would look like if it were wrong. A document with no stated failure conditions is hard to review and harder to maintain.
-
A single out-of-range value on an otherwise normal panel Replied, post #70 · Clinical › Bloodwork · 9 Jul 2026 · 8 likes On post #68 — agreed on the reasoning, with one qualification. Add biological variation and analytical imprecision to that base rate and the probability of a…
-
Request: a per-category review queue Replied, post #86 · Meta › Feature requests · 7 Jul 2026 · 25 likes The arithmetic in post #83 is right; the assumption feeding it is the part to check. Small methodological point on per-category review queue: repeating a measurement is…
-
How much context is too much context in a first post? Replied, post #27 · Start Here › How to Ask · 6 Jul 2026 · 12 likes Edit the first post rather than adding the missing detail in reply nine. People arriving later read the first post and stop.
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #79 · Compounds › Repair & healing peptides · 26 Jun 2026 · 22 likes Post #77 and I disagree about the size of the effect, not about the direction. Stability of BPC-157 is well covered in the tag pages, and the older discussions are…
-
Coming back to: Time to steady state after a dose increase Replied, post #82 · Pharmacology › Pharmacokinetics · 21 Jun 2026 · 0 likes A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the pharmacokinetic reason the labelling does not recommend doubling. Not a…
-
Pages past their review date, listed — does this still hold? Replied, post #20 · Meta › Wiki maintenance · 21 Jun 2026 · 25 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Pooling trials with different estimands Replied, post #20 · Evidence › Meta-analyses · 12 Jun 2026 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
-
Follow-up: The retatrutide phase 2 obesity paper, read closely Replied, post #17 · Compounds › Retatrutide · 9 Jun 2026 · 13 likes Picking up post #16: that is the part I would want checked first. A theoretical mass for retatrutide is not published in the peer-reviewed literature in a form worth…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #54 · Practice › Storage & stability · 5 Jun 2026 · 0 likes Adding what did not work for me on reconstituted, since the failures never get written up and they are half the useful information.
-
An appeal that succeeded, with the letter structure — the long version Replied, post #31 · Access › Insurance & coverage · 30 May 2026 · 4 likes Appeal deadlines are strict and are stated in the letter. Missing one is the most avoidable way to lose. One of those cases where knowing the mechanism does not help…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #16 · Access › Pricing · 29 May 2026 · 0 likes Post #14 describes the usual case. This is about the unusual one. The version of comparing prices across jurisdictions that circulates here is a simplification of a…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #2 · Access › Insurance & coverage · 21 May 2026 · 7 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Reimbursement changes: a compound covered one year might not be the next. A…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #124 · Devices › Syringes & needles · 16 May 2026 · 32 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. Old…
-
Coming back to: A structured critique template this community uses Replied, post #10 · Evidence › Study critique · 12 May 2026 · 1 like Noted, and thank you for writing it out rather than summarising it.
-
Revisiting: What pooling buys you and what it destroys Replied, post #15 · Evidence › Meta-analyses · 6 May 2026 · 10 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
Designing a personal experiment that could change your mind — one year on Replied, post #31 · Research Methods › N-of-1 designs · 9 Apr 2026 · 1 like Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid. It…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #28 · Meta › Announcements · 9 Apr 2026 · 28 likes One question about the transition rather than the policy: what happens to topics that are in flight when it takes effect? The announcement is clear about posts and…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #32 · Evidence › Journal club · 4 Apr 2026 · 0 likes Adding a small correction to the SURMOUNT-1 summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Follow-up: Evidence quality in the secretagogue literature: an honest assessment Replied, post #23 · Compounds › Secretagogues & GH axis · 31 Mar 2026 · 0 likes The arithmetic in post #20 is right; the assumption feeding it is the part to check. The pulsatile character of endogenous growth hormone release is why a secretagogue…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #31 · Practice › Administration · 29 Mar 2026 · 7 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
A calculator that gives a right answer to the wrong question Replied, post #11 · Data & Tools › Calculators · 22 Mar 2026 · 0 likes Coming back to post #9, because the follow-up matters more than the original answer. Storage lookup: which conditions (temperature, time) are you considering storing…
-
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 2 Mar 2026 · 27 likes Thank you — that answers what I came here to find out.
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #31 · Compounds › Other compounds · 20 Feb 2026 · 16 likes Adding the measurement that post #28 says would settle it. Storage guidance for the less common material is usually copied from the incretin guidance and may not apply.…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #132 · Analytics › Home & field testing · 11 Feb 2026 · 9 likes Post #129 describes the usual case. This is about the unusual one. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #79 · Sourcing › Red flags · 5 Feb 2026 · 4 likes Confirming post #78 from a second method, which matters more than confirming it from a second person. Inconsistency across documents: a certificate stating one purity,…
-
[2026 update] Long-time reader, first-time poster Replied, post #43 · Lounge › Introductions · 19 Jan 2026 · 0 likes No spam: introductions are not a place to advertise commercial products or services. That is a rules violation.
-
Storing lyophilised material long term: what governs the shelf life Replied, post #31 · Practice › Storage & stability · 19 Jan 2026 · 22 likes Good question, well framed, and I would like to see it answered properly.
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #49 · Practice › Side effects · 28 Dec 2025 · 0 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #8 · Sourcing › Vendor reports · 25 Dec 2025 · 28 likes Answering the question post #6 raises rather than the one it answers. Photograph the vial and the label before opening. It costs ten seconds and it is what turns a…
-
Micro-titration: a disputed topic, argued properly Replied, post #14 · Practice › Dosing & titration · 21 Dec 2025 · 4 likes Where I part company with post #12, and it is a narrow parting. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
The decimal-point error, and the habit that catches it Replied, post #71 · Practice › Reconstitution · 16 Dec 2025 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #24 · Practice › Dosing & titration · 7 Dec 2025 · 0 likes Stepping down deliberately: the withdrawal trials show that stopping is followed by regain. The step-down literature is thinner. The conservative assumption is that…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #16 · Practice › Interactions · 5 Dec 2025 · 0 likes Anything that also slows gut motility compounds the same mechanism. That is a plausibility argument rather than a documented interaction, and it should be labelled as…
-
EMA product information as a primary source Replied, post #22 · Regional › European Union · 1 Nov 2025 · 10 likes Coming back to post #20, because the follow-up matters more than the original answer. Where the EMA product information discussion usually stalls is that nobody wants…
-
Second pass at: Circumference measurements as a poor man's composition estimate Replied, post #10 · Outcomes › Body composition · 30 Oct 2025 · 6 likes Picking up post #7: that is the part I would want checked first. Genuine question rather than a rhetorical one: has anyone here actually observed Circumference…
-
Journal club: LEADER as the historical anchor Started this topic · Evidence › Journal club · 29 Oct 2025 · 3 likes Journal club: LEADER as the historical anchor Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of…
-
Appeal templates and why they are deliberately unemotional Replied, post #19 · Access › Insurance & coverage · 19 Oct 2025 · 4 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Pen mechanics when the cartridge is nearly empty — does this still hold? Replied, post #4 · Devices › Pens & autoinjectors · 8 Oct 2025 · 6 likes I read the opening post twice before replying, because I had assumed the opposite. Dose counters: pens show the remaining number of doses. When the counter reaches…
-
Liver enzymes drifting down and what that usually means Replied, post #14 · Clinical › Bloodwork · 26 Sep 2025 · 11 likes The arithmetic on liver enzymes drifting is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #58 · Evidence › Study critique · 14 Sep 2025 · 0 likes Something worth flagging about Reverse causation: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not…
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #3 · Evidence › Journal club · 31 Aug 2025 · 4 likes Everything in the opening post holds. The case it does not cover is the one I have. Sessions on negative or null results are consistently the most instructive and the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #85 · Access › Shortages · 10 Aug 2025 · 15 likes Everything in post #83 holds. The case it does not cover is the one I have. Regional differences during a shortage are large, and a supply position in one country says…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #14 · Practice › Dosing & titration · 20 Jul 2025 · 25 likes Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you…
-
Measurement error in home scales, with a worked standard deviation — a second dataset Started this topic · Research Methods › Statistics · 13 Jul 2025 · 0 likes Measurement error in home scales, with a worked standard deviation — a second dataset — setting out what I have, and where I think it stops being reliable. Posting a…
-
Which panel is worth repeating and which is worth ignoring Replied, post #45 · Clinical › Bloodwork · 24 Jun 2025 · 19 likes Post #41 describes the usual case. This is about the unusual one. Checked the panel claim against the primary source this morning. It survives, with a narrower scope…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #17 · Analytics › Method validation · 17 Jun 2025 · 18 likes Post #15 is right about the mechanism and I think understates the practical bit. Adding a small correction to the Forced degradation studies summary above rather than a…
-
A report I filed that turned out to be wrong, and the correction Replied, post #102 · Sourcing › Vendor reports · 14 Jun 2025 · 23 likes On post #98 — agreed on the reasoning, with one qualification. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #4 · Practice › Side effects · 10 Jun 2025 · 0 likes Confirming post #3 from a second method, which matters more than confirming it from a second person. One more thing on Constipation management that took me far too long…
-
Criticising the method without criticising the authors — one year on Replied, post #4 · Evidence › Study critique · 29 May 2025 · 16 likes The opening post and I disagree about the size of the effect, not about the direction. Multiple comparisons without adjustment is a defensible choice when declared in…
-
Pre-registering a personal experiment, seriously Replied, post #16 · Research Methods › N-of-1 designs · 26 May 2025 · 33 likes Record everything that changed, not just the intervention. Personal experiments are confounded by life, and the confounders are only recoverable if they were written…
-
Travel coolers and how long they really hold — the long version Replied, post #24 · Devices › Cold chain · 23 May 2025 · 0 likes Travel coolers looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Titles that describe the question, not the situation Replied, post #14 · Start Here › How to Ask · 21 May 2025 · 1 like No disagreement from me. Posting only so the question does not look ignored.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #5 · Compounds › Oral incretins · 8 May 2025 · 3 likes I would put moderate confidence on the mainstream reading of oral semaglutide and no more. That is not scepticism for its own sake; it is where the sourcing actually…
-
Coming back to: Official shortage notices and what they authorise Replied, post #3 · Access › Shortages · 8 May 2025 · 17 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Reading an MS report that only gives you a single number Replied, post #66 · Analytics › Mass spectrometry · 30 Apr 2025 · 0 likes Resolution and mass accuracy are different specifications. An instrument can resolve two species and still assign their masses imprecisely, and the reverse is also…
-
Water content on a certificate and why it changes the arithmetic Replied, post #3 · Analytics › COA interpretation · 21 Apr 2025 · 0 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Coverage for the indication versus for the drug — a second dataset Replied, post #26 · Access › Insurance & coverage · 18 Mar 2025 · 14 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #78 · Access › International · 4 Mar 2025 · 32 likes Building on post #76 rather than restating it. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #20 · Evidence › Journal club · 2 Mar 2025 · 0 likes The practical version of SURMOUNT-OSA is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #14 · Analytics › COA interpretation · 20 Feb 2025 · 15 likes Adding the measurement that post #11 says would settle it. Counter-ion form is a question about a distribution, not about a value, and treating it as a value is what…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #9 · Access › Pricing · 13 Feb 2025 · 22 likes Nothing here is financial advice and none of it is a route to a transaction.
-
Distinguishing a deletion sequence by mass alone Replied, post #72 · Analytics › Mass spectrometry · 10 Feb 2025 · 11 likes Post #70 describes the usual case. This is about the unusual one. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #43 · Clinical › Bloodwork · 4 Feb 2025 · 7 likes Where I part company with post #40, and it is a narrow parting. I would rather this thread reach "we do not know" about Lipid changes during rapid weight than reach a…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #74 · Sourcing › Regulatory · 30 Jan 2025 · 7 likes This follows post #71 rather than contradicting it. Adding a small correction to the Research-use-only labelling summary above rather than a disagreement with it. The…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #4 · Clinical › Comorbidities · 26 Jan 2025 · 2 likes Chronic kidney disease: compounds in this class have renal benefit in people with kidney disease. The benefit appears to be additive to other renal-protective agents,…
-
Second pass at: Regression to the mean in progress reports Replied, post #31 · Research Methods › Statistics · 21 Jan 2025 · 7 likes Adding a small correction to the Regression summary above rather than a disagreement with it. The substance holds; one of the figures is out by a factor that matters.
-
Individual participant data versus aggregate data Replied, post #14 · Evidence › Meta-analyses · 10 Jan 2025 · 0 likes Building on post #13 rather than restating it. Sensitivity analysis: the authors re-run the meta-analysis excluding studies one at a time, or by quality, to see whether…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #112 · Compounds › Tirzepatide · 27 Dec 2024 · 17 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
-
Anaesthesia and elective surgery: the aspiration question — does this still hold? Replied, post #13 · Practice › Interactions · 16 Dec 2024 · 32 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #19 · Data & Tools › Calculators · 14 Dec 2024 · 15 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
-
Triple agonism: additive, synergistic, or neither? Replied, post #3 · marked as the solution · Compounds › Retatrutide · 10 Dec 2024 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison…
-
Promotion criteria, and the one that stops most nominations Replied, post #111 · Documentation › Doc review · 12 Nov 2024 · 29 likes I read the earlier replies on promotion criteria twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #24 · Compounds › Repair & healing peptides · 10 Nov 2024 · 0 likes Where I part company with post #22, and it is a narrow parting. A note on how reading a preclinical wound-healing model gets discussed rather than on reading a…
-
Irish differences from the UK position Replied, post #66 · Regional › UK & Ireland · 30 Oct 2024 · 0 likes Private prescribing arrangements differ in what they include, and the differences are more consequential than the headline price.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #44 · Access › Shortages · 10 Oct 2024 · 0 likes Manufacturer allocation decisions during a shortage are commercial and are rarely explained, which is frustrating and is not evidence of anything. The interesting part…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #74 · Practice › Dosing & titration · 1 Oct 2024 · 0 likes Post #70 put the caveat in the right place and I want to underline it. The documentation on four-week escalation interval is better than this thread and I say that as…
-
Converting between mg/mL and units per dose, both directions Replied, post #36 · Practice › Reconstitution · 1 Oct 2024 · 10 likes Confirming post #35 from a second method, which matters more than confirming it from a second person. Preservative effectiveness is tested against a defined microbial…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #23 · Compounds › Tirzepatide · 27 Sep 2024 · 13 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
Follow-up: Oral contraceptives and delayed emptying: what the data shows Replied, post #9 · Practice › Interactions · 6 Aug 2024 · 8 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #50 · Compounds › Retatrutide · 19 Jul 2024 · 10 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #22 · Evidence › Journal club · 13 Jul 2024 · 2 likes This settles it for me, at least until somebody posts a reason it should not.
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #26 · Practice › Interactions · 10 Jul 2024 · 21 likes Where I part company with post #24, and it is a narrow parting. Oral medications with a narrow therapeutic index are the ones where that matters most. The interaction…